The Role of Vitamins and Minerals in Hair Loss: A Review – Body Health World
[ad_1]
Bronsnick T, Murzaku EC, Rao BK. Diet in dermatology: Part I. Atopic dermatitis, acne, and nonmelanoma skin cancer. J Am Acad Dermatol. 2014;71(6):1039e1–e12.
Murzaku EC, Bronsnick T, Rao BK. Diet in dermatology: Part II. Melanoma, chronic urticaria, and psoriasis. J Am Acad Dermatol. 2014;71(6):1053e1–e16.
Shapiro J. Clinical practice Hair loss in women. N Engl J Med. 2007;357(16):1620–30.
Gg A. Diffuse alopecia; nutritional factors and supplements. Turkderm-Turk Arch Dermatol Venerol. 2014;48[Suppl 1]:45–7.
Mason JB. Vitamins, trace minerals, and other micronutrients. In: Goldman L., Schafer AI, editors. Goldman-Cecil Medicine. 25 ed. Philadelphia, PA: Saunders, an imprint of Elsevier Inc.; 2016, p. 1445–1455.e1441.
Stewart CP. GDLs. A treatise on scurvy. Edinburgh: Edinburgh University Press; 1953:145–8.
Bradfield RB, Bailley MA. Hair root response to protein undernutrition. In: Montagna WDRL, ed. Biology of skin hair growth, vol. 9. Oxford: Pergamon Press; 1969:109–19.
Sims RT. The measurement of hair growth as an index of protein synthesis in malnutrition. Br J Nutr. 1968;22(2):229–36.
Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007;36(2):379–98.
Handjiski BK, Eichmuller S, Hofmann U, Czarnetzki BM, Paus R. Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol. 1994;131(3):303–10.
Johnson EJRR. Encyclopedia of dietary supplements. 2nd ed. London and New York: Informa Healthcare; 2010:115–20.
Ca R, Vitamin A. Encyclopedia of dietary supplements. 2nd ed. London and New York: Informa Healthcare; 2010:778–91.
Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.
Vitamins and minerals: B vitamins and folic acid NHS choices. Washington, DC: National Health Service; 2017. https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-b/. Accessed 8 Aug 2018.
Yamamoto K, Sadahito K, Yoshikawa M, et al. Hyena disease (premature physeal closure) in calves due to overdose of vitamins A, D3, E. Vet Hum Toxicol. 2003;45(2):85–7.
McLaren DS, Loveridge N, Duthie G, Bolton-Smith C. Fat soluble vitamins. In: Garrow JS, James WPT, eds. Human nutrition, dietetics. 9th edn. Edinburgh: Churchill Livingstone; 1993.
Hathcock J. Nutritional toxicology. New York: Academic Press; 1982.
Everts HB. Endogenous retinoids in the hair follicle and sebaceous gland. Biochim Biophys Acta. 2012;1821(1):222–9.
Kmiec ML, Pajor A, Broniarczyk-Dyla G. Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin. Postepy Dermatol Alergol. 2013;30(6):343–9.
Shmunes E. Hypervitaminosis A in a patient with alopecia receiving renal dialysis. Arch Dermatol. 1979;115(7):882–3.
Cheruvattath R, Orrego M, Gautam M, et al. Vitamin A toxicity: when one a day doesn’t keep the doctor away. Liver Transpl. 2006;12(12):1888–91.
Institute of Medicine, Food and Nutrition Board. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin b6, folate, vitamin b12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 1998.
Said HM, Ross A. Riboflavin. Modern nutrition in health and disease, 11th edn. Baltimore: Lippincott Williams & Wilkins; 2014:325–30.
Riboflavin Rs R. Encyclopedia of dietary supplements. London and New York: Informa Healthcare; 2010:691–9.
Zempleni JWS, Kuroishi T. Biotin. Present knowledge in nutrition. 10th edn. Washington, DC: Wiley-Blackwell; 2012. p. 359–74.
Mock DM. Biotin. In: Coates PM, Blackman M, Betz JM, Cragg GM, Levine MA, Moss J, White JD, editors. Encyclopedia of dietary supplements, edn 2. London, New York: Informa Healthcare; 2010. p. 43–51.
Tzellos TG, Tahmatzidis DK, Lallas A, Apostolidou K, Goulis DG. Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis. J Diabetes Complic. 2009;23(6):434–7.
U.S. Food and Drug Administration (FDA). The FDA warns that biotin may interfere with lab tests: FDA safety communication. Washington, DC: FDA, U.S. Department of Health and Human Services; 2017. Updated 28 Nov 2017. https://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm586505.htm.
Samarasinghe S, Meah F, Singh V, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr Pract. 2017;23(8):989–98.
Wijeratne NG, Doery JC, Lu ZX. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology. 2012;44(7):674–5.
Trambas CM, Sikaris KA, Lu ZX. More on biotin treatment mimicking Graves’ disease. N Engl J Med. 2016;375(17):1698.
Batista MC, Ferreira CES, Faulhaber ACL, Hidal JT, Lottenberg SA, Mangueira CLP. Biotin interference in immunoassays mimicking subclinical Graves’ disease and hyperestrogenism: a case series. Clin Chem Lab Med. 2017;55(6):e99–103.
Williams GR, Cervinski MA, Nerenz RD. Assessment of biotin interference with qualitative point-of-care hCG test devices. Clin Biochem. 2018;53:168–70.
Goldberg LJ, Lenzy Y. Nutrition and hair. Clin Dermatol. 2010;28(4):412–9.
Durusoy C, Ozenli Y, Adiguzel A, et al. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study. Clin Exp Dermatol. 2009;34(7):789–92.
Zempleni J, Hassan YI, Wijeratne SS. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab. 2008;3(6):715–24.
Boccaletti V, Zendri E, Giordano G, Gnetti L, De Panfilis G. Familial uncombable hair syndrome: ultrastructural hair study and response to biotin. Pediatr Dermatol. 2007;24(3):E14–6.
Shelley WB, Shelley ED. Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia. J Am Acad Dermatol. 1985;13(1):97–102.
Trueb RM. Serum biotin levels in women complaining of hair loss. Int J Trichol. 2016;8(2):73–7.
Daulatabad D, Singal A, Grover C, Chhillar N. Prospective analytical controlled study evaluating serum biotin, vitamin b12, and folic acid in patients with premature canities. Int J Trichol. 2017;9(1):19–24.
Carmel R. Folic Acid. In: Shils M, Shike M, Ross A, Caballero B, Cousins R, editors. Modern nutrition in health and disease. Baltimore: Lippincott Williams & Wilkins; 2005. p. 470–81.
Bailey RL, Dodd KW, Gahche JJ, et al. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003–2006. Am J Clin Nutr. 2010;91(1):231–7.
Harvard TH, Chan School of Public Health. Three of the B vitamins: folate, vitamin B6, and vitamin B12. Boston, MA: Harvard T.H. Chan School of Public Health; 2018. Accessed 8 Aug 2018.
Gonul M, Cakmak SK, Soylu S, Kilic A, Gul U. Serum vitamin B12, folate, ferritin, and iron levels in Turkish patients with alopecia areata. Indian J Dermatol Venereol Leprol. 2009;75(5):552.
Ertugrul DT, Karadag AS, Takci Z, et al. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in alopecia areata patients. Cutan Ocul Toxicol. 2013;32(1):1–3.
Yousefi M, Namazi MR, Rahimi H, Younespour S, Ehsani AH, Shakoei S. Evaluation of serum homocysteine, high-sensitivity CRP, and RBC folate in patients with alopecia areata. Indian J Dermatol. 2014;59(6):630.
Kalkan G, Yigit S, Karakus N, et al. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population. Gene. 2013;530(1):109–12.
Cheung EJ, Sink JR, English Iii JC. Vitamin and mineral deficiencies in patients with Telogen Effluvium: a retrospective cross-sectional study. J Drugs Dermatol. 2016;15(10):1235–7.
Ramsay ID, Rushton DH. Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia. Clin Exp Dermatol. 1990;15(4):277–81.
Valdes F. Vitamin C. Actas Dermosifiliogr. 2006;97(9):557–68.
Gropper SS, Smith J, Grodd JL. The water-soluble vitamins. In: Gropper SS, Smith JL, Grodd JL, editors. Advanced nutrition and human metabolism, 4th edn. Belmont: Thomson Wadsworth; 2004: 260–75.
Fleming JD, Martin B, Card DJ, Mellerio JE. Pain, purpura and curly hairs. Clin Exp Dermatol. 2013;38(8):940–2.
Kechichian E, Ezzedine K. Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol. 2018;19(2):223–35.
D’Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev. 2015;14(5):363–9.
Thompson JM, Mirza MA, Park MK, Qureshi AA, Cho E. The role of micronutrients in alopecia areata: a review. Am J Clin Dermatol. 2017;18(5):663–79.
Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36.
Zhang X, Wang W, Li Y, Wang H, Liu R, Zhu L. Serum 25-hydroxyvitamin D status in chinese children with vitiligo: a case–control study. Clin Pediatr (Phila). 2018;57(7):802–5.
Djeraba Z, Benlabidi F, Djaballah-Ider FZ, Medjeber O, Arroul-Lammali A, Belguendouz H, et al. Vitamin D status in Algerian Behcet’s disease patients: an immunomodulatory effect on NO pathway. Immunopharmacol Immunotoxicol. 2017;39(4):243–50.
Wang LM, Zheng ZH, Li TF, et al. 25-hydroxyvitamin D is associated with metabolic syndrome among premenopausal women with systemic lupus erythematosus in China. Lupus. 2017;26(4):403–9.
Vasile M, Corinaldesi C, Antinozzi C, Crescioli C. Vitamin D in autoimmune rheumatic diseases: a view inside gender differences. Pharmacol Res. 2017;117:228–41.
Reichrath J, Schilli M, Kerber A, Bahmer FA, Czarnetzki BM, Paus R. Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol. 1994;131(4):477–82.
Takeda E, Kuroda Y, Saijo T, et al. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics. 1987;80(1):97–101.
Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev. 1999;20(2):156–88.
Vupperla D, Lunge SB, Elaprolu P. Vitamin D-dependent rickets Type II with alopecia: a rare case report. Indian J Dermatol. 2018;63(2):176–9.
Forghani N, Lum C, Krishnan S, et al. Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene. J Pediatr Endocrinol Metab. 2010;23(8):843–50.
Aksu Cerman A, Sarikaya Solak S, Kivanc Altunay I. Vitamin D deficiency in alopecia areata. Br J Dermatol. 2014;170(6):1299–304.
Mahamid M, Abu-Elhija O, Samamra M, Mahamid A, Nseir W. Association between vitamin D levels and alopecia areata. Isr Med Assoc J. 2014;16(6):367–70.
Lee S, Kim BJ, Lee CH, Lee WS. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(7):1214–21.
Thompson JM, Li T, Park MK, Qureshi AA, Cho E. Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women. Arch Dermatol Res. 2016;308(9):671–6.
Gade VKV, Mony A, Munisamy M, Chandrashekar L, Rajappa M. An investigation of vitamin D status in alopecia areata. Clin Exp Med. 2018;18(4):577–84.
Daroach M, Narang T, Saikia UN, Sachdeva N, Sendhil Kumaran M. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. Int J Dermatol. 2018;57(2):217–22.
Rasheed H, Mahgoub D, Hegazy R, et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26(2):101–7.
Banihashemi M, Nahidi Y, Meibodi NT, Jarahi L, Dolatkhah M. Serum vitamin D3 level in patients with female pattern hair loss. Int J Trichol. 2016;8(3):116–20.
Moneib HFG, Ouda A. Possible association of female-pattern hair loss with alteration in serum 25-hydroxyvitamin D levels. Egypt J Dermatol Venerol. 2014;34:15–20.
Nayak K, Garg A, Mithra P, Manjrekar P. Serum vitamin D3 levels and diffuse hair fall among the student population in South India: a case–control study. Int J Trichol. 2016;8(4):160–4.
Karadag ASEDT, Tutal E, Akin KO. The role of anemia and vitamin D levels in acute and chronic telogen effluvium. Turk J Med Sci. 2011;41:827–33.
Gerkowicz A, Chyl-Surdacka K, Krasowska D, Chodorowska G. The role of vitamin D in non-scarring alopecia. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms18122653.
Knight JA. Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci. 2000;30(2):145–58.
Prie BE, Voiculescu VM, Ionescu-Bozdog OB, et al. Oxidative stress and alopecia areata. J Med Life. 2015;8(Spec Issue):43–6.
Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct. 2000;18(3):169–73.
Ramadan R, Tawdy A, Abdel Hay R, Rashed L, Tawfik D. The antioxidant role of paraoxonase 1 and vitamin E in three autoimmune diseases. Skin Pharmacol Physiol. 2013;26(1):2–7.
Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824–44.
Shrivastava SB. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009;75(1):20–7 (quiz 7–8).
Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol. 1973;26(10):770–2.
Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404.
Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002;147(5):982–4.
Coenen JL, van Dieijen-Visser MP, van Pelt J, et al. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem. 1991;37(4):560–3.
Rushton DH, Ramsay ID. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol (Oxf). 1992;36(4):421–7.
Milman N, Kirchhoff M. Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin. Ann Hematol. 1992;64(1):22–7.
Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hulten L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85(4):787–98.
Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052–7.
Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44(1):45–51.
St Pierre SA, Vercellotti GM, Donovan JC, Hordinsky MK. Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle. J Am Acad Dermatol. 2010;63(6):1070–6.
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121(5):985–8.
Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389–95.
Rushton DH, Barth JH. What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol. 2010;73(1):1–9.
Rushton DH, Dover R, Sainsbury AW, Norris MJ, Gilkes JJ, Ramsay ID. Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ. 2001;322(7298):1355–7.
Hard S. Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol. 1963;43:562–9.
Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol. 1990;123(2):187–97.
Rushton DH, Norris MJ, Dover R, Busuttil N. Causes of hair loss and the developments in hair rejuvenation. Int J Cosmet Sci. 2002;24(1):17–23.
White MI, Currie J, Williams MP. A study of the tissue iron status of patients with alopecia areata. Br J Dermatol. 1994;130(2):261–3.
Aydingoz IE, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol. 1999;13(1):65–7.
Boffa MJ, Wood P, Griffiths CE. Iron status of patients with alopecia areata. Br J Dermatol. 1995;132(4):662–4.
Bregy A, Trueb RM. No association between serum ferritin levels > 10 microg/l and hair loss activity in women. Dermatology. 2008;217(1):1–6.
Rushton DH, Dover R, Norris MJ. Is there really no clear association between low serum ferritin and chronic diffuse telogen hair loss? Br J Dermatol. 2003;148(6):1282–4 (author reply 4).
Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol. 2010;63(6):991–9.
Rushton DH, Bergfeld WF, Gilkes JJ, Van Neste D. Iron deficiency and hair loss–nothing new? J Am Acad Dermatol. 2011;65(1):203–4 (author reply 4-6).
Olsen EARK. Untangling the hairy issue of iron deficiency: making progress. J Am Acad Dermatol. 2011;65(1):204–6.
Gowda D, Premalatha V, Imtiyaz DB. Prevalence of nutritional deficiencies in hair loss among Indian participants: results of a Cross-sectional Study. Int J Trichol. 2017;9(3):101–4.
Deo K, Sharma YK, Wadhokar M, Tyagi N. Clinicoepidemiological Observational Study of acquired alopecias in females correlating with anemia and thyroid function. Dermatol Res Pract. 2016;2016:6279108.
Dastgheib L, Mostafavi-Pour Z, Abdorazagh AA, et al. Comparison of zn, cu, and fe content in hair and serum in alopecia areata patients with normal group. Dermatol Res Pract. 2014;2014:784863.
Esfandiarpour I, Farajzadeh S, Abbaszadeh M. Evaluation of serum iron and ferritin levels in alopecia areata. Dermatol Online J. 2008;14(3):21.
Mussalo-Rauhamaa H, Lakomaa EL, Kianto U, Lehto J. Element concentrations in serum, erythrocytes, hair and urine of alopecia patients. Acta Derm Venereol. 1986;66(2):103–9.
Bhat RM, Sharma R, Pinto AC, Dandekeri S, Martis J. Epidemiological and investigative study of premature graying of hair in higher secondary and pre-university school children. Int J Trichol. 2013;5(1):17–21.
Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320(5879):1088–92.
Ohyama M, Terunuma A, Tock CL, et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006;116(1):249–60.
Vinton NE, Dahlstrom KA, Strobel CT, Ament ME. Macrocytosis and pseudoalbinism: manifestations of selenium deficiency. J Pediatr. 1987;111(5):711–7.
Masumoto K, Nagata K, Higashi M, et al. Clinical features of selenium deficiency in infants receiving long-term nutritional support. Nutrition. 2007;23(11–12):782–7.
Petru E, Petru C, Benedicic C. Re: “Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy”. Gynecol Oncol. 2005;96(2):559 (author reply -60).
Fan AM, Kizer KW. Selenium. Nutritional, toxicologic, and clinical aspects. West J Med. 1990;153(2):160–7.
MacFarquhar JK, Broussard DL, Melstrom P, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010;170(3):256–61.
Goskowicz M, Eichenfield LF. Cutaneous findings of nutritional deficiencies in children. Curr Opin Pediatr. 1993;5(4):441–5.
Alhaj E, Alhaj N, Alhaj NE. Diffuse alopecia in a child due to dietary zinc deficiency. Skinmed. 2007;6(4):199–200.
Kil MS, Kim CW, Kim SS. Analysis of serum zinc and copper concentrations in hair loss. Ann Dermatol. 2013;25(4):405–9.
Yavuz IH, Yavuz GO, Bilgili SG, Demir H, Demir C. Assessment of heavy metal and trace element levels in patients with telogen effluvium. Indian J Dermatol. 2018;63(3):246–50.
Abdel Fattah NS, Atef MM, Al-Qaradaghi SM. Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata. Int J Dermatol. 2016;55(1):24–9.
Ead RD. Oral zinc sulphate in alopacia areata-a double blind trial. Br J Dermatol. 1981;104(4):483–4.
Park H, Kim CW, Kim SS, Park CW. The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level. Ann Dermatol. 2009;21(2):142–6.
Passi S, Morrone A, De Luca C, Picardo M, Ippolito F. Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrheic dermatitis. J Dermatol Sci. 1991;2(3):171–8.
Wirth H, Gloor M, Swoboda U. Oral zinc therapy and sebaceous gland secretion (author’s transl). Z Hautkr. 1981;56(7):447–51.
Filoni A, Vestita M, Congedo M, Giudice G, Tafuri S, Bonamonte D. Association between psoriasis and vitamin D: duration of disease correlates with decreased vitamin D serum levels: An observational case-control study. Medicine (Baltimore). 2018;97(25):e11185.
Finner AM. Nutrition and hair: deficiencies and supplements. Dermatol Clin. 2013;31(1):167–72.
Goette DK, Odom RB. Alopecia in crash dieters. JAMA. 1976;235(24):2622–3.
Krusinski PA. Letter: telogen effluvium secondary to weight loss and therapy with chorionic gonadotropin. Arch Dermatol. 1976;112(4):556.
Kaufman JP. Letter: telogen effluvium secondary to starvation diet. Arch Dermatol. 1976;112(5):731.
Boisvert A. Liquid protein diets and telogen effluvium: a case report. Ann Pharmacother. 1978;12(8):490–1.
Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol. 1990;23(6 Pt 1):1127–32.
[ad_2]
